Trials / Terminated
TerminatedNCT02396225
Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Concentrations of voriconazole in pulmonary epithelial lining fluid and in serum are compared after inhalation of 40 mg voriconazole b.i.d. for two days or oral intake of voriconazole tablets 400 mg bid for 1 day followed by 200 mg b.i.d. for one day, respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Voriconazole |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-03-24
- Last updated
- 2017-05-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02396225. Inclusion in this directory is not an endorsement.